查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1541099

2024-2032 年按產品、應用、最終用途和地區分類的病毒去活化市場報告

Viral Inactivation Market Report by Product, Application, End Use, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 2-3個工作天內

價格

IMARC Group年，全球病毒去活化市場規模達6.356億美元。

生物治療產品含有病毒，或在生產過程中可能受到污染。病毒是侵入細胞的傳染性顆粒，它們在細胞中增殖並導致各種疾病。因此，病毒去活化被廣泛用於抑制病毒內的外殼蛋白和分解核酸。目前，根據病毒的特性和生物治療產品的類型，全球範圍內有不同的病毒去活化方法。例如，殺菌 (UVC) 光照射有助於去活化醫院和其他重要公共和軍事環境中的病毒。

病毒去活化市場趨勢：

人體血液是有助於預防和治療危及生命的疾病的藥物的來源。人們越來越擔心血源性病毒會透過血漿來源的藥物傳播，這是影響世界各地病毒去活化需求的重要因素之一。如今，使用多種病毒去活化程序來確保血漿來源的蛋白質溶液的安全性。此外，許多國家的管理機構在生物治療產品開發的早期階段就引入了嚴格的監管標準。這些標準不斷提高對病毒去活化的需求，以確保這些產品的品質、安全性和有效性，從而降低交叉污染的風險。除此之外，食品和飲料（F&B）行業正在採用改進的病毒去活化技術和產品，以幫助控制腸病毒的傳播並確保產品的安全。這與超臨界流體、氣體等離子體和脈衝電場等新物理方法的發展相結合，預計將提高病毒去活化的可靠性、便利性和適用性，從而推動市場發展。

本報告回答的關鍵問題：

  • 迄今為止，全球病毒去活化市場的表現如何，未來幾年又將如何表現？
  • COVID-19 對全球病毒去活化市場有何影響？
  • 主要區域市場有哪些？
  • 基於產品的市場區隔是什麼？
  • 基於應用的市場區隔是什麼？
  • 根據最終用途分類的市場是怎樣的？
  • 產業價值鏈的各個階段是什麼？
  • 該行業的關鍵促進因素和挑戰是什麼？
  • 全球病毒去活化市場的結構如何？
  • 產業競爭程度如何？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 數據來源
    • 主要來源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球病毒去活化市場

  • 市場概況
  • 市場表現
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依產品

  • 試劑和試劑盒
    • 市場趨勢
    • 市場預測
  • 系統
    • 市場趨勢
    • 市場預測
  • 服務
    • 市場趨勢
    • 市場預測

第 7 章：市場區隔：按應用

  • 疫苗和治療方法
    • 市場趨勢
    • 市場預測
  • 幹細胞產品
    • 市場趨勢
    • 市場預測
  • 血液和血液製品
    • 市場趨勢
    • 市場預測
  • 組織和組織產品
    • 市場趨勢
    • 市場預測
  • 細胞和基因治療
    • 市場趨勢
    • 市場預測

第 8 章：市場區隔：最終用途別

  • 製藥和生物技術公司
    • 市場趨勢
    • 市場預測
  • 合約研究組織
    • 市場趨勢
    • 市場預測
  • 學術及研究機構
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 9 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場趨勢
    • 市場細分：按國家/地區
    • 市場預測

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Charles River Laboratories
    • Merck KGaA
    • Parker Hannifin Corp
    • Rad Source Technologies
    • Sartorius AG
    • SGS SA
    • Terumo Corporation
    • Texcell
    • Vironova AB
    • WuXi AppTec
Product Code: SR112024A4115

The global viral inactivation market size reached US$ 635.6 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,390.8 Million by 2032, exhibiting a growth rate (CAGR) of 8.8% during 2024-2032.

Biotherapeutic products contain viruses or they can become contaminated during the production process. Viruses are infectious particles that invade cells wherein they proliferate and result in various diseases. As a result, viral inactivation is widely used to inhibit coat proteins and degrade nucleic acid within the virus. At present, different methods of viral inactivation are available across the globe according to the characteristics of the virus and the type of biotherapeutic product. For instance, germicidal (UVC) light exposure helps inactivate viruses in hospitals and other critical public and military environments.

Viral Inactivation Market Trends:

Human blood is a source of medicinal products that assists in the prevention and treatment of life-threatening diseases. Rising concerns about the transmission of blood-borne viruses through plasma-derived medicinal products represent one of the significant factors influencing the need for viral inactivation around the world. Several procedures for viral inactivation are nowadays used to assure the safety of blood plasma-derived protein solutions. Moreover, governing agencies of numerous countries are introducing stringent regulatory standards at an early stage in the development of biotherapeutic products. These standards are escalating the demand for viral inactivation to ensure the quality, safety, and efficacy of these products, thereby reducing the risk of cross-contamination. Apart from this, improved viral inactivation technologies and products are being employed in the food and beverage (F&B) industry to help control the transmission of enteric viruses and assure the safety of products. This, in confluence with the development of new physical methods like supercritical fluids, gas plasma, and pulsed electric fields, is anticipated to increase the reliability, convenience, and suitability of viral inactivation, thereby driving the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global viral inactivation market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, application and end use.

Breakup by Product:

Reagents and Kits

Systems

Services

Breakup by Application:

Vaccines and Therapeutics

Stem Cell Products

Blood and Blood Products

Tissue and Tissue Products

Cellular and Gene Therapy

Breakup by End Use:

Pharmaceutical and Biotechnology Companies

CROs

Academic and Research Institutes

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Charles River Laboratories, Merck KGaA, Parker Hannifin Corp, Rad Source Technologies, Sartorius AG, SGS SA, Terumo Corporation, Texcell, Vironova AB and WuXi AppTec.

Key Questions Answered in This Report:

  • How has the global viral inactivation market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global viral inactivation market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end use?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global viral inactivation market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Viral Inactivation Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Reagents and Kits
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Systems
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Services
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Vaccines and Therapeutics
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Stem Cell Products
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Blood and Blood Products
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Tissue and Tissue Products
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Cellular and Gene Therapy
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End Use

  • 8.1 Pharmaceutical and Biotechnology Companies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 CROs
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Academic and Research Institutes
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Charles River Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Merck KGaA
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Parker Hannifin Corp
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Rad Source Technologies
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 SWOT Analysis
    • 14.3.5 Sartorius AG
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 SGS SA
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
    • 14.3.7 Terumo Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Texcell
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Vironova AB
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 WuXi AppTec
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials

List of Figures

  • Figure 1: Global: Viral Inactivation Market: Major Drivers and Challenges
  • Figure 2: Global: Viral Inactivation Market: Sales Value (in Million US$), 2018-2023
  • Figure 3: Global: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 4: Global: Viral Inactivation Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Viral Inactivation Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Viral Inactivation Market: Breakup by End Use (in %), 2023
  • Figure 7: Global: Viral Inactivation Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Viral Inactivation (Reagents and Kits) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Viral Inactivation (Reagents and Kits) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Viral Inactivation (Systems) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Viral Inactivation (Systems) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Viral Inactivation (Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Viral Inactivation (Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Viral Inactivation (Vaccines and Therapeutics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Viral Inactivation (Vaccines and Therapeutics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Viral Inactivation (Stem Cell Products) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Viral Inactivation (Stem Cell Products) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Viral Inactivation (Blood and Blood Products) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Viral Inactivation (Blood and Blood Products) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Viral Inactivation (Tissue and Tissue Products) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Viral Inactivation (Tissue and Tissue Products) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Viral Inactivation (Cellular and Gene Therapy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Viral Inactivation (Cellular and Gene Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Viral Inactivation (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Viral Inactivation (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Viral Inactivation (CROs) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Viral Inactivation (CROs) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Viral Inactivation (Academic and Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Viral Inactivation (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Viral Inactivation (Other End Uses) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Viral Inactivation (Other End Uses) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: North America: Viral Inactivation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: North America: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: United States: Viral Inactivation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: United States: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Canada: Viral Inactivation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Canada: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Asia-Pacific: Viral Inactivation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Asia-Pacific: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: China: Viral Inactivation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: China: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Japan: Viral Inactivation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Japan: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: India: Viral Inactivation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: India: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: South Korea: Viral Inactivation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: South Korea: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Australia: Viral Inactivation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Australia: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Indonesia: Viral Inactivation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Indonesia: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Others: Viral Inactivation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Others: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Europe: Viral Inactivation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Europe: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Germany: Viral Inactivation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Germany: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: France: Viral Inactivation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: France: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: United Kingdom: Viral Inactivation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: United Kingdom: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Italy: Viral Inactivation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Italy: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Spain: Viral Inactivation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Spain: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Russia: Viral Inactivation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Russia: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Others: Viral Inactivation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Others: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Latin America: Viral Inactivation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Latin America: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Brazil: Viral Inactivation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Brazil: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Mexico: Viral Inactivation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Mexico: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Others: Viral Inactivation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Others: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Middle East and Africa: Viral Inactivation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Middle East and Africa: Viral Inactivation Market: Breakup by Country (in %), 2023
  • Figure 80: Middle East and Africa: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Global: Viral Inactivation Industry: SWOT Analysis
  • Figure 82: Global: Viral Inactivation Industry: Value Chain Analysis
  • Figure 83: Global: Viral Inactivation Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Viral Inactivation Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Viral Inactivation Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Viral Inactivation Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Viral Inactivation Market Forecast: Breakup by End Use (in Million US$), 2024-2032
  • Table 5: Global: Viral Inactivation Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Viral Inactivation Market: Competitive Structure
  • Table 7: Global: Viral Inactivation Market: Key Players